Show simple item record

dc.contributor.editorAraki, Toshiyuki
dc.date.accessioned2022-05-22T01:34:55Z
dc.date.available2022-05-22T01:34:55Z
dc.date.issued2021-07-25
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/81840
dc.description.abstractAmyotrophic lateral sclerosis is a fatal, progressive neurodegenerative disorder characterized by motor neuron cell death in the brain and spinal cord. The typical disease symptom is the rapid loss of muscle control, which eventually leads to the complete paralysis of voluntary muscles of the entire body. There is no curative treatment for amyotrophic lateral sclerosis. The rarity of the disease and the difficulties in accurate early diagnosis are the major challenges in the proper understanding of the disease and the development of curative therapy. This book brings together a team of experts, both clinicians and basic scientists, to provide a comprehensive understanding of amyotrophic lateral sclerosis, challenges, and approaches to combat this devastating disease. The clinical chapters provide excellent views of diagnosis, pathology, management, and the problem of diagnostic delay. The basic science chapters provide a comprehensive description of pathomechanisms and therapies with emphasis on dysfunctional astrocytes, impaired synaptic transmission, defective axonal transport, biomarkers, cell-based therapies, and gut microbiota. The book is primarily aimed at clinicians and basic scientists; however, it will likely be of interest to a wide audience interested in amyotrophic lateral sclerosis.en_US
dc.languageEnglishen_US
dc.subject.classificationMJNen_US
dc.subject.otherClinical Manifestation of Amyotrophic Lateral Sclerosis; Management of Amyotrophic Lateral Sclerosis; Diagnostic Delay in Amyotrophic Lateral Sclerosis; Astrocytes in Amyotrophic Lateral Sclerosis; Synaptic Transmission in Amyotrophic Lateral Sclerosis; Motoneuron Excitability Defects in Amyotrophic Lateral Sclerosis; Axonal Transport in Amyotrophic Lateral Sclerosis; Blood-based Biomarkers for Amyotrophic Lateral Sclerosis; Cell Therapy for Amyotrophic Lateral Sclerosis; Gut Microbiota in Amyotrophic Lateral Sclerosisen_US
dc.titleAmyotrophic Lateral Sclerosisen_US
dc.typebook
dc.description.versionPublisheden_US
oapen.identifier.doi10.36255/exonpublications.amyotrophiclateralsclerosis.2021en_US
oapen.relation.isPublishedBy2d6001a3-9e06-4979-bf02-6974e313eb24
oapen.relation.isbn9780645001778en_US
oapen.pages162en_US
oapen.place.publicationAustraliaen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/